Medicare Enrolled

Dr. Eugene Wyszynski, DO

Hematology & Oncology · Farmers Branch, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
9 MEDICAL PKWY STE 210, Farmers Branch, TX 75234
2144496511
In practice since 2006 (19 years)
NPI: 1760431845 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wyszynski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wyszynski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wyszynski

Dr. Eugene Wyszynski is a hematology & oncology in Farmers Branch, TX, with 19 years in practice. Based on federal Medicare data, Dr. Wyszynski performed 99 Medicare services across 47 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wyszynski received a total of $19,134 from 76 pharmaceutical and/or device companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wyszynski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 99 Medicare services$ $19,134 industry payments

Medicare Practice Summary

Medicare Utilization ↗
99
Medicare services
Bottom 7% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
47
Unique beneficiaries
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)76$134$388
Office visit, established patient (30-39 min)23$99$263
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,134
Total received (2018-2024)
Avg $2,733/year across 7 years
Top 21% in TX for hematology & oncology
76
Companies
608
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,822 (46.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,850 (30.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,462 (12.9%)
Other
Charitable contributions, space rental, and other categories
$1,999 (10.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$415
2023
$781
2022
$3,324
2021
$2,762
2020
$1,465
2019
$3,715
2018
$6,671

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,735
Novartis Pharmaceuticals Corporation
$2,442
Amgen Inc.
$2,387
Janssen Biotech, Inc.
$1,978
Incyte Corporation
$1,088
PFIZER INC.
$982
E.R. Squibb & Sons, L.L.C.
$585
Astellas Pharma US Inc
$576
Merck Sharp & Dohme Corporation
$481
Deciphera Pharmaceuticals Inc.
$455
Takeda Pharmaceuticals U.S.A., Inc.
$337
Celgene Corporation
$326
EISAI INC.
$243
Gilead Sciences, Inc.
$230
Eisai Inc.
$220
Pharmacyclics LLC, An AbbVie Company
$204
Foundation Medicine, Inc.
$193
Sirtex Medical Inc
$179
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Blueprint Medicines Corporation
$164
Octapharma USA, Inc.
$163
Rigel Pharmaceuticals, Inc.
$156
Genentech USA, Inc.
$146
Madrigal Pharmaceuticals
$130
Boehringer Ingelheim Pharmaceuticals, Inc.
$124
Kowa Pharmaceuticals America, Inc.
$124
EMD Serono, Inc.
$119
Kite Pharma, Inc.
$118
Taiho Oncology, Inc.
$110
Janssen Products, LP
$100
Bayer HealthCare Pharmaceuticals Inc.
$97
Dova Pharmaceuticals
$94
Acrotech Biopharma LLC
$88
Ipsen Biopharmaceuticals, Inc
$80
Daiichi Sankyo Inc.
$78
Exelixis Inc.
$78
Lexicon Pharmaceuticals, Inc.
$78
Regeneron Healthcare Solutions, Inc.
$75
Sun Pharmaceutical Industries Inc.
$68
GENZYME CORPORATION
$60
Merck Sharp & Dohme LLC
$59
Karyopharm Therapeutics Inc.
$56
INSYS Therapeutics Inc
$53
Genentech, Inc.
$50
Teva Pharmaceuticals USA, Inc.
$47
AbbVie, Inc.
$47
Myovant Sciences Inc.
$46
Clovis Oncology, Inc.
$45
Coherus Biosciences Inc.
$40
AMAG Pharmaceuticals, Inc.
$39
Mindray DS USA, Inc.
$39
Sobi, Inc
$38
GlaxoSmithKline, LLC.
$36
TESARO, Inc.
$36
AngioDynamics, Inc.
$35
Advanced Accelerator Applications
$34
ARRAY BIOPHARMA INC
$31
Janssen Pharmaceuticals, Inc
$27
MEDIVATION FIELD SOLUTIONS LLC
$24
Adaptive Biotechnologies Corporation
$23
MENARINI SILICON BIOSYSTEMS, INC.
$22
Bio Products Laboratory USA, Inc.
$21
Accord Healthcare, Inc.
$21
Heron Therapeutics, Inc.
$21
Kyowa Kirin, Inc.
$19
Dendreon Pharmaceuticals LLC
$19
Verity Pharmaceuticals Inc.
$18
EUSA Pharma (US) LLC
$18
Shire North American Group Inc
$17
Alnylam Pharmaceuticals Inc.
$16
Stemline Therapeutics Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
Seattle Genetics, Inc.
$12
Tactile Systems Technology Inc
$12
Epizyme, Inc.,
$11
Top 3 companies account for 39.5% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · AYVAKIT · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BOSULIF · BRAFTOVI · Bavencio · CALQUENCE · CAMCEVI · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELITEK · ELZONRIS · ENHERTU · ERLEADA · EVENITY · Enhertu · Erivedge · Erleada · FARESTON · FERAHEME · FOUNDATIONACT · FOUNDATIONONE · Flexitouch Plus · Folotyn · GAVRETO · GILOTRIF · GIVLAARI · Gammaplex · HYQVIA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JARDIANCE · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Livalo · Lonsurf · MEKINIST · MONJUVI · MVASI · NINLARO · NUWIQ · Neulasta · Nplate · Nubeqa · ODOMZO · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · Perjeta · Pomalyst · QINLOCK · REBLOZYL · REZDIFFRA · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TAZVERIK · TE7 MAX · TECENTRIQ · Tavalisse · Trelstar · Trodelvy · Udenyca · VOTRIENT · Vectibix · Venclexta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xtandi · YERVOY · YONSA · Yescarta · ZEJULA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (46%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $19,327 per 100 Medicare services performed
Looking for a hematology & oncology in Farmers Branch?
Compare hematology & oncologys in the Farmers Branch area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
136
Per 100K population
5.2
County median income
$74,149
Nearest hospital
DALLAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wyszynski is a clinical cardiology specialist, with moderate Medicare volume, and mixed engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Wyszynski experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Wyszynski performed 76 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wyszynski receive payments from pharmaceutical companies?
Yes. Dr. Wyszynski received a total of $19,134 from 76 companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wyszynski's costs compare to other hematology & oncologys in Farmers Branch?
Dr. Wyszynski's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wyszynski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →